Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Ivonescimab(AK112/SMT112) in Combination With Stereotactic Body Radiation Therapy and Chemotherapy in Patients With Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL
- Status
- RECRUITING
- Phase
- PHASE2
Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
AG Combined With Cadonilimab Sequential Short-course Radiotherapy in the Treatment of Locally aPDAC
- Status
- RECRUITING
- Phase
- PHASE2
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Adebrelimab With or Without SHR-8068 in Combination With Cisplatin Plus Gemcitabine as First-line Treatment in Patients With Advanced Biliary Tract Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study of IMM01 Plus Tiselizumab Versus Physician's Choice Chemotherapy in PD(L)1-refractory Classical Hodgkin Lymphoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer
- Status
- RECRUITING
- Phase
- PHASE4
Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of QLS31905 and/or QL1706 Combination With Chemotherapy in the Advanced Malignant Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Prospective, Single-arm, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy.
- Status
- RECRUITING
- Phase
- PHASE2